RTVP-1 mRNA expression was significantly higher in GBM compared with the control group (median log expression with interquartile range, 2.06±0.69 in GBM vs. 1.33±0.26 in non-tumor brain; P<0.001); (Fig. 2B). The gene discussed is GLIPR1; the disease is glioblastoma.